Mode
Text Size
Log in / Sign up
N/A N=524 Randomized Prevention

Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

Enrolled (actual)
524
Serious AEs
41.7%
Results posted
Jun 2024
Primary outcome: Primary: Ventilator-free Days (VFDs) — 18.4; 16.1 days

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Sigh breaths (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Minnesota
Primary completion
Oct 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Ventilator-free Days (VFDs)
18.4; 16.1
SECONDARY
All-cause Mortality
30; 46
SECONDARY
ICU-free Days
13.7; 11.9
SECONDARY
Number of Participants With Complications of Treatment
18; 20; 57; 69; 127; 120
SECONDARY
Discharge Status
6; 5
SECONDARY
Number of Participants Requiring Oxygen Therapy at Discharge
20; 12

Summary

A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.

Eligibility Criteria

Inclusion Criteria

Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation who also have one or more of the following:

  • Traumatic brain injury
  • > 1 long bone fractures
  • Shock on arrival in the Emergency Department (systolic BP 6 units of blood

Exclusion Criteria

  • Inability to obtain consent from the patient or his/her legally authorized representative (LAR)
  • Unwillingness of the treating physician to use sigh ventilation as all treating physicians must have equipoise with respect to the intervention
  • Age limitations per Institutional Review Board regulations
  • Undergoing invasive mechanical ventilation for > 24 hours, excluding any time during which the patient was being ventilated in the operating room, CT or IR, as this could represent too long a delay in instituting the intervention for it to have a chance of being effective
  • Presence of malignancy or other irreversible disease or condition for which the six month mortality is estimated to exceed 50% (e.g., chronic liver disease with a Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect the clinical course and cloud interpretation of the endpoints
  • Women who are pregnant (negative pregnancy tests required on women of child-bearing age) per Human Subjects regulations
  • Prisoners, per Human Subjects regulations
  • Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher spinal cord injury as this could affect the clinical course and cloud interpretation of the ventilator-free day endpoint
  • Lack of availability of Dräger Evita Infinity V500 ventilator as this is the only ventilator capable of delivering sigh breaths as described in the protocol
  • Burns > 40% of body surface area as this could affect the clinical course and cloud interpretation of the endpoints
  • Treating physicians being unwilling to use low VT ventilation strategy when ARDS is diagnosed as low VT ventilation is now considered standard of care for patients with ARDS.
  • Moribund, not expected to survive 24 hours as this could affect the clinical course and cloud interpretation of the endpoints13. Treating physician's decision to use airway pressure release ventilation (APRV).
  • Patient not expected to require mechanical ventilation > 24 hours (e.g., intubated for alcohol intoxication rather than pulmonary problem).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02582957). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search